Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096358239> ?p ?o ?g. }
- W3096358239 endingPage "14365" @default.
- W3096358239 startingPage "14349" @default.
- W3096358239 abstract "Colorectal carcinoma (CRC) recurrence is often accompanied by metastasis. Most metastasis undergo through epithelial-mesenchymal transition (EMT). Studies showed that retinol X receptor alpha (RXRα) and 20(S)-Protopanaxadiol (PPD) have anti-tumour effects. However, the anti-metastasis effect of 20(S)-PPD and the effect of RXRα on EMT-induced metastasis are few studies on. Therefore, the role of RXRα and 20(S)-PPD in CRC cell metastasis remains to be fully elucidated. RXRα with clinicopathological characteristics and EMT-related expression in clinical samples were examined. Then, RXRα and EMT level in SW480 and SW620 cells, overexpressed and silenced RXRα in SW620 cells and SW480 cells, respectively, were evaluated. Finally, 20(S)-PPD effect on SW620 and SW480 cells was evaluated. The results showed that a lower RXRα expression in cancer tissues, and a moderate negative correlation between RXRα and N stage, and tended to higher level of EMT. SW480 and SW620 cells had the highest and lowest RXRα expression among four CRC cell lines. SW480 had lower EMT level than SW620. Furthermore, 20(S)-PPD increased RXRα and inhibited EMT level in SW620 cell. Finally, 20(S)-PPD cannot restore SW480 cells EMT level to normal when RXRα silencing. These findings suggest that 20(S)-PPD may inhibit EMT process in CRC cells by regulating RXRα expression." @default.
- W3096358239 created "2020-11-09" @default.
- W3096358239 creator A5010398730 @default.
- W3096358239 creator A5028964644 @default.
- W3096358239 creator A5035375708 @default.
- W3096358239 creator A5063131315 @default.
- W3096358239 creator A5063208324 @default.
- W3096358239 creator A5065843053 @default.
- W3096358239 creator A5066608422 @default.
- W3096358239 creator A5069557001 @default.
- W3096358239 creator A5076510658 @default.
- W3096358239 creator A5083452187 @default.
- W3096358239 date "2020-10-30" @default.
- W3096358239 modified "2023-10-05" @default.
- W3096358239 title "20(<i>S</i>)‐Protopanaxadiol inhibits epithelial‐mesenchymal transition by promoting retinoid X receptor alpha in human colorectal carcinoma cells" @default.
- W3096358239 cites W1622461349 @default.
- W3096358239 cites W1742988325 @default.
- W3096358239 cites W1898345195 @default.
- W3096358239 cites W1967135261 @default.
- W3096358239 cites W1972018679 @default.
- W3096358239 cites W1982774276 @default.
- W3096358239 cites W1985083844 @default.
- W3096358239 cites W1987473368 @default.
- W3096358239 cites W1991690216 @default.
- W3096358239 cites W1998294362 @default.
- W3096358239 cites W1999669689 @default.
- W3096358239 cites W2002652075 @default.
- W3096358239 cites W2009569201 @default.
- W3096358239 cites W2010325861 @default.
- W3096358239 cites W2017430900 @default.
- W3096358239 cites W2036541245 @default.
- W3096358239 cites W2046163257 @default.
- W3096358239 cites W2052566122 @default.
- W3096358239 cites W2054495264 @default.
- W3096358239 cites W2062954284 @default.
- W3096358239 cites W2064579441 @default.
- W3096358239 cites W2065477695 @default.
- W3096358239 cites W2069243037 @default.
- W3096358239 cites W2069347152 @default.
- W3096358239 cites W2069480855 @default.
- W3096358239 cites W2079153927 @default.
- W3096358239 cites W2082046119 @default.
- W3096358239 cites W2093531978 @default.
- W3096358239 cites W2095902558 @default.
- W3096358239 cites W2101146378 @default.
- W3096358239 cites W2101997514 @default.
- W3096358239 cites W2110378444 @default.
- W3096358239 cites W2120981549 @default.
- W3096358239 cites W2122808667 @default.
- W3096358239 cites W2132820593 @default.
- W3096358239 cites W2144680000 @default.
- W3096358239 cites W2150054925 @default.
- W3096358239 cites W2155158934 @default.
- W3096358239 cites W2164954416 @default.
- W3096358239 cites W2182959467 @default.
- W3096358239 cites W2228878779 @default.
- W3096358239 cites W2258412324 @default.
- W3096358239 cites W2482712364 @default.
- W3096358239 cites W2746036157 @default.
- W3096358239 cites W2772808988 @default.
- W3096358239 cites W2794610215 @default.
- W3096358239 cites W2795718561 @default.
- W3096358239 cites W2799970137 @default.
- W3096358239 cites W2886093832 @default.
- W3096358239 cites W2889990998 @default.
- W3096358239 cites W2910600894 @default.
- W3096358239 cites W2921147303 @default.
- W3096358239 cites W2921579381 @default.
- W3096358239 cites W2935814637 @default.
- W3096358239 cites W2944504961 @default.
- W3096358239 cites W2967189612 @default.
- W3096358239 cites W2976018446 @default.
- W3096358239 cites W2981518057 @default.
- W3096358239 cites W2997218091 @default.
- W3096358239 cites W3009963727 @default.
- W3096358239 cites W3025876384 @default.
- W3096358239 cites W3096358239 @default.
- W3096358239 cites W332081358 @default.
- W3096358239 cites W4296253742 @default.
- W3096358239 doi "https://doi.org/10.1111/jcmm.16054" @default.
- W3096358239 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7754066" @default.
- W3096358239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33128348" @default.
- W3096358239 hasPublicationYear "2020" @default.
- W3096358239 type Work @default.
- W3096358239 sameAs 3096358239 @default.
- W3096358239 citedByCount "8" @default.
- W3096358239 countsByYear W30963582392020 @default.
- W3096358239 countsByYear W30963582392022 @default.
- W3096358239 countsByYear W30963582392023 @default.
- W3096358239 crossrefType "journal-article" @default.
- W3096358239 hasAuthorship W3096358239A5010398730 @default.
- W3096358239 hasAuthorship W3096358239A5028964644 @default.
- W3096358239 hasAuthorship W3096358239A5035375708 @default.
- W3096358239 hasAuthorship W3096358239A5063131315 @default.
- W3096358239 hasAuthorship W3096358239A5063208324 @default.
- W3096358239 hasAuthorship W3096358239A5065843053 @default.
- W3096358239 hasAuthorship W3096358239A5066608422 @default.
- W3096358239 hasAuthorship W3096358239A5069557001 @default.